Sign in

CIK 0001237831

  • Large accelerated filer

GLOBUS MEDICAL INC

Sign in to watch
Ticker
GMED
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043744954
Phone
+1 610-930-1800
Business address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,794,049
in 3 filings, $425K under 10b5-1 plans

Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$5.4M Director sold 100% of stake
  2. RHOADS ANN D −$425K Director sold 12% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-27 RHOADS ANN D Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2022-01-27 Lemaitre Dan Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2022-01-27 Davidar David D Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2022-01-27 Huller Kelly SVP, GC, Corporate Secretary Grant or award · Stock Option (Right to Buy Class A Common Stock) +30,000 30,000
2022-01-27 Pfeil Keith W SVP, Chief Financial Officer Grant or award · Stock Option (Right to Buy Class A Common Stock) +40,000 40,000
2022-01-27 Scavilla Daniel T EVP, Chief Commercial Officer Grant or award · Stock Option (Right to Buy Class A Common Stock) +40,000 40,000
2022-01-27 Demski David M President, CEO Grant or award · Stock Option (Right to Buy Class A Common Stock) +150,000 150,000
2022-01-27 Paul David C Executive Chairman Grant or award · Stock Option (Right to Buy Class A Common Stock) +75,000 75,000
2021-09-08 Davidar David D Director Gift −2,000 632,775
2021-08-19 Pfeil Keith W SVP, Chief Financial Officer Exercise or conversion +833 $49.65 $41K 833
2021-08-19 Pfeil Keith W SVP, Chief Financial Officer Sale −833 $76.13 $63K 0
2021-08-19 Pfeil Keith W SVP, Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −833 20,000
2021-08-19 Pfeil Keith W SVP, Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −0 24,167
2021-08-19 Pfeil Keith W SVP, Chief Financial Officer Exercise or conversion +833 $53.27 $44K 833
2021-08-19 Pfeil Keith W SVP, Chief Financial Officer Sale −833 $76.13 $63K 0
2021-08-19 Pfeil Keith W SVP, Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −833 23,334
2021-08-02 Pfeil Keith W SVP, Chief Financial Officer Exercise or conversion +833 $53.27 $44K 833
2021-08-02 Pfeil Keith W SVP, Chief Financial Officer Sale −833 $83.24 $69K 0
2021-08-02 Pfeil Keith W SVP, Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −833 24,167
2021-07-19 Pfeil Keith W SVP, Chief Financial Officer Exercise or conversion +834 $49.65 $41K 834

Page 13 of 25 · 498 trades